GTX-B001

· Granular Therapeutics Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GTX-B001, covering 2026-01-30 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria [Phase 1]